Follow
Ranjeet Dash
Ranjeet Dash
Senior Scientist, The Janssen Pharmaceutical Companies of Johnson & Johnson
Verified email at its.jnj.com - Homepage
Title
Cited by
Cited by
Year
Role of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route
R Pathak, RP Dash, M Misra, M Nivsarkar
Acta Pharmaceutica Sinica B 4 (2), 151-160, 2014
1152014
Antithrombocytopenic activity of carpaine and alkaloidal extract of Carica papaya Linn. leaves in busulfan induced thrombocytopenic Wistar rats
V Zunjar, RP Dash, M Jivrajani, B Trivedi, M Nivsarkar
Journal of ethnopharmacology 181, 20-25, 2016
1032016
Gastrointestinal-resident, shape-changing microdevices extend drug release in vivo
A Ghosh, L Li, L Xu, RP Dash, N Gupta, J Lam, Q Jin, V Akshintala, ...
Science advances 6 (44), eabb4133, 2020
922020
Therapeutic potential and utility of elacridar with respect to P-glycoprotein inhibition: an insight from the published in vitro, preclinical and clinical studies
RP Dash, R Jayachandra Babu, NR Srinivas
European journal of drug metabolism and pharmacokinetics 42, 915-933, 2017
792017
N-(Pivaloyloxy)alkoxy-carbonyl Prodrugs of the Glutamine Antagonist 6-Diazo-5-oxo-l-norleucine (DON) as a Potential Treatment for HIV Associated …
MT Nedelcovych, L Tenora, BH Kim, J Kelschenbach, W Chao, E Hadas, ...
Journal of medicinal chemistry 60 (16), 7186-7198, 2017
702017
Two decades-long journey from riluzole to edaravone: Revisiting the clinical pharmacokinetics of the only two amyotrophic lateral sclerosis therapeutics
RP Dash, NR Babu, R Jayachandra, Srinivas
Clinical Pharmacokinetics, 2018
682018
Reappraisal and perspectives of clinical drug–drug interaction potential of α-glucosidase inhibitors such as acarbose, voglibose and miglitol in the treatment of type 2 …
RP Dash, RJ Babu, NR Srinivas
Xenobiotica 48 (1), 89-108, 2018
562018
Discovery of DRP-104, a tumor-targeted metabolic inhibitor prodrug
R Rais, KM Lemberg, L Tenora, ML Arwood, A Pal, J Alt, Y Wu, J Lam, ...
Science advances 8 (46), eabq5925, 2022
502022
Critical assessment of pharmacokinetic drug–drug interaction potential of tofacitinib, baricitinib and upadacitinib, the three approved janus kinase inhibitors for rheumatoid …
V Veeravalli, RP Dash, JA Thomas, RJ Babu, LMV Madgula, NR Srinivas
Drug safety 43, 711-725, 2020
492020
Comparative pharmacokinetic profiles of picrosides I and II from kutkin, Picrorhiza kurroa extract and its formulation in rats
D Upadhyay, RP Dash, S Anandjiwala, M Nivsarkar
Fitoterapia 85, 76-83, 2013
432013
N-substituted prodrugs of mebendazole provide improved aqueous solubility and oral bioavailability in mice and dogs
SC Zimmermann, T Tichý, J Vávra, RP Dash, EC Slusher, AJ Gadiano, ...
Journal of Medicinal Chemistry, 2018
422018
Simultaneous quantification of berberine and lysergol by HPLC‐UV: evidence that lysergol enhances the oral bioavailability of berberine in rats
S Patil, RP Dash, S Anandjiwala, M Nivsarkar
Biomedical Chromatography 26 (10), 1170-1175, 2012
412012
Tumor-Targeted Delivery of 6-Diazo-5-oxo-l-norleucine (DON) Using Substituted Acetylated Lysine Prodrugs
L Tenora, J Alt, RP Dash, AJ Gadiano, K Novotna, V Veeravalli, J Lam, ...
Journal of medicinal chemistry 62 (7), 3524-3538, 2019
392019
Novel human neutral sphingomyelinase 2 inhibitors as potential therapeutics for Alzheimer’s disease
M Šála, KR Hollinger, AG Thomas, RP Dash, C Tallon, V Veeravalli, ...
Journal of medicinal chemistry 63 (11), 6028-6056, 2020
372020
Design, synthesis and biological evaluation of novel pyrazolo-pyrimidinones as DPP-IV inhibitors in diabetes
SR Sagar, JK Agarwal, DH Pandya, RP Dash, M Nivsarkar, KK Vasu
Bioorganic & Medicinal Chemistry Letters 25 (20), 4428-4433, 2015
362015
Review of the pharmacokinetics of dalbavancin, a recently approved lipoglycopeptide antibiotic
RP Dash, RJ Babu, NR Srinivas
Infectious Diseases 49 (7), 483-492, 2017
342017
A novel and potent brain penetrant inhibitor of extracellular vesicle release
C Rojas, M Sala, AG Thomas, A Datta Chaudhuri, SW Yoo, Z Li, RP Dash, ...
British journal of pharmacology 176 (19), 3857-3870, 2019
332019
Glutamine antagonist JHU083 normalizes aberrant glutamate production and cognitive deficits in the EcoHIV murine model of HIV-associated neurocognitive disorders
MT Nedelcovych, BH Kim, X Zhu, LE Lovell, AA Manning, J Kelschenbach, ...
Journal of Neuroimmune Pharmacology 14, 391-400, 2019
332019
Use of sorbitol as pharmaceutical excipient in the present day formulations–issues and challenges for drug absorption and bioavailability
RP Dash, NR Srinivas, RJ Babu
Drug development and industrial pharmacy 45 (9), 1421-1429, 2019
332019
Evaluation of GABAergic Transmission Modulation as a Novel Functional Target for Management of Multiple Sclerosis: Exploring Inhibitory Effect of GABA on Glutamate‐Mediated …
AA Gilani, RP Dash, MN Jivrajani, SK Thakur, M Nivsarkar
Advances in Pharmacological and Pharmaceutical Sciences 2014 (1), 632376, 2014
262014
The system can't perform the operation now. Try again later.
Articles 1–20